1. Home
  2. DRDB vs CTNM Comparison

DRDB vs CTNM Comparison

Compare DRDB & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DRDB

Roman DBDR Acquisition Corp. II Ordinary shares

HOLD

Current Price

$10.42

Market Cap

319.5M

Sector

N/A

ML Signal

HOLD

Logo Contineum Therapeutics Inc. Class A Common Stock

CTNM

Contineum Therapeutics Inc. Class A Common Stock

HOLD

Current Price

$12.25

Market Cap

328.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRDB
CTNM
Founded
2024
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
319.5M
328.1M
IPO Year
2024
2024

Fundamental Metrics

Financial Performance
Metric
DRDB
CTNM
Price
$10.42
$12.25
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.00
AVG Volume (30 Days)
57.5K
171.0K
Earning Date
01-01-0001
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$595.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.87
$3.35
52 Week High
$10.47
$15.25

Technical Indicators

Market Signals
Indicator
DRDB
CTNM
Relative Strength Index (RSI) 47.42 59.69
Support Level $10.43 $10.42
Resistance Level $10.47 $11.43
Average True Range (ATR) 0.01 0.83
MACD -0.01 0.06
Stochastic Oscillator 9.09 68.45

Price Performance

Historical Comparison
DRDB
CTNM

About DRDB Roman DBDR Acquisition Corp. II Ordinary shares

Roman DBDR Acquisition Corp II is a blank check company.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: